x
Turning science into breakthroughs
Enabling promising new drug research across a wide range of therapeutic areas
The University of North Carolina at Chapel Hill and Deerfield Management have entered into a partnership to create Pinnacle Hill, a company seeking to discover new medicines to address the significant unmet medical needs of our times.
Deerfield will invest up to $65 million of targeted funding through Pinnacle Hill, as well as providing significant drug development expertise to advance promising therapeutic research at UNC-Chapel Hill.
Pinnacle Hill will focus on drug research projects that are approved and directed by a joint steering committee comprised of members from UNC-Chapel Hill and Deerfield leadership teams. Each selected project will be sufficiently funded to support investigational new drug enabling studies.
Deerfield is a healthcare investment management firm committed to advancing healthcare through investment, information and philanthropy. For more information, please visit www.deerfield.com.
The University of North Carolina at Chapel Hill, the nation’s first public university, is a global higher education leader known for innovative teaching, research and public service. For more information, please visit www.unc.edu.
Project Submissions
To learn more about project sourcing and evaluation, please reach out to us directly.
Updates from Cure.
Cure. is a Deerfield affiliate and premier healthcare innovation ecosystem headquartered in New York City, with a mission to accelerate cures by helping health innovators develop groundbreaking products and services from concept to commercialization.
Content is generated and provided by third parties, including Cure, an affiliate of Pinnacle Hill and Deerfield, and has not been reviewed or approved by Pinnacle Hill or Deerfield.